Delcath Systems (DCTH)
Commercializing HEPZATO in the United States and CHEMOSAT in Europe for liver-directed oncology.
$15.96
vs last close−0.44 (−2.68%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.10
Revenue estimate
$26.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.05$0.03$0.07$0.02−$0.05−$0.03$0.07Pending
Estimate−$0.10$0.10$0.03$0.02−$0.06−$0.09−$0.09−$0.10
Surprise+150.0%−70.0%+169.2%0.0%+20.6%+68.1%+178.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$15.1M$19.8M$24.2M$20.6M$20.7M$25.0M$29.1MPending
Estimate$16.7M$18.6M$23.0M$20.4M$20.6M$23.5M$26.3M$26.0M
Surprise−9.4%+6.1%+4.9%+1.0%+0.7%+6.3%+11.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.02 | — | — |
| Sep 2028 | −$0.03 | — | — |
| Jun 2028 | $0.02 | — | — |
| Mar 2028 | −$0.01 | — | — |
| Dec 2027 | −$0.05 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | $0.01 | — | — |
| Mar 2027 | −$0.05 | — | — |
| Dec 2026 | −$0.14 | — | — |
| Nov 2026 | −$0.10 | — | — |
| Aug 2026 | −$0.09 | $0.07 | +178.5% |
| May 2026 | −$0.09 | −$0.03 | +68.1% |
| Feb 2026 | −$0.06 | −$0.05 | +20.6% |
| Nov 2025 | $0.02 | $0.02 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jul 2019 | |||
| Jun 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.02 | — | — | $41.9M | — | — | — |
| Sep 2028 | −$0.03 | — | — | $39.3M | — | — | — |
| Jun 2028 | $0.02 | — | — | $41.3M | — | — | — |
| Mar 2028 | −$0.01 | — | — | $39.8M | — | — | — |
| Dec 2027 | −$0.05 | — | — | $35.0M | — | — | — |
| Sep 2027 | −$0.06 | — | — | $33.4M | — | — | — |
| Jun 2027 | $0.01 | — | — | $36.1M | — | — | — |
| Mar 2027 | −$0.05 | — | — | $32.3M | — | — | — |
| Dec 2026 | −$0.14 | — | — | $26.3M | — | — | — |
| Nov 3, 2026 | −$0.10 | — | — | $26.0M | — | — | — |
| Aug 6, 2026 | −$0.09 | $0.07 | +178.5% | $26.3M | $29.1M | +11.0% | +22.5% |
| May 7, 2026 | −$0.09 | −$0.03 | +68.1% | $23.5M | $25.0M | +6.3% | −0.2% |
| Feb 26, 2026 | −$0.06 | −$0.05 | +20.6% | $20.6M | $20.7M | +0.7% | −11.9% |
| Nov 4, 2025 | $0.02 | $0.02 | 0.0% | $20.4M | $20.6M | +1.0% | −4.6% |
| Aug 6, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 22, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 25, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 11, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 25, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 8, 2019 | |||||||
| Jul 17, 2019 | |||||||
| Jun 14, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 15, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 16, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 29, 2017 | |||||||
| Nov 11, 2016 | |||||||
| Aug 16, 2016 | |||||||
| May 4, 2016 | |||||||
| Mar 21, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 5, 2015 |